SCHRODER INVESTMENT MANAGEMENT GROUP - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 106 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2019$6,455,000
+14.0%
84,800
+27.9%
0.01%
+10.0%
Q2 2019$5,663,000
-2.4%
66,300
+23.5%
0.01%0.0%
Q1 2019$5,804,000
+106.3%
53,700
+119.9%
0.01%
+100.0%
Q2 2018$2,814,000
-89.0%
24,416
-90.5%
0.01%
-88.6%
Q1 2018$25,467,000
-43.0%
257,920
-39.5%
0.04%
-39.7%
Q4 2017$44,654,000
-29.0%
426,455
-24.2%
0.07%
-33.0%
Q3 2017$62,937,000
-17.8%
562,438
-17.4%
0.11%
-21.0%
Q2 2017$76,585,000
-56.1%
681,242
-53.0%
0.14%
-12.1%
Q1 2017$174,388,000
+99.7%
1,449,004
+74.7%
0.16%
-6.0%
Q4 2016$87,336,000
-9.0%
829,641
-4.4%
0.17%
-6.7%
Q3 2016$95,946,000
-21.2%
868,219
+3.8%
0.18%
-26.6%
Q2 2016$121,739,000
+23.6%
836,119
+20.5%
0.24%
+19.6%
Q1 2016$98,516,000
+60.0%
694,068
+74.2%
0.20%
+60.6%
Q4 2015$61,564,000
+42.3%
398,341
+31.6%
0.13%
+39.6%
Q3 2015$43,254,000
+2229.2%
302,704
+2210.7%
0.09%
+2175.0%
Q2 2015$1,857,000
-100.0%
13,100
-95.4%
0.00%
-93.2%
Q3 2014$44,009,807,000
+1.0%
286,038
-8.0%
0.06%
+9.3%
Q2 2014$43,586,592,000310,8000.05%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q2 2019
NameSharesValueWeighting ↓
ISZO CAPITAL MANAGEMENT LP 582,409$90,011,00060.33%
GUARDIAN POINT CAPITAL, LP 70,000$10,819,00010.19%
Think Investments LP 186,373$28,804,0008.16%
Greywolf Capital Management LP 277,936$42,955,0007.45%
Valentine Capital Asset Management, Inc. 28,431$4,394,0004.91%
FORT, L.P. 63,675$9,841,0004.69%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 527,266$81,489,0003.63%
RPG Investment Advisory, LLC 60,910$9,413,0003.52%
Kerrisdale Advisers, LLC 81,996$12,672,0003.24%
Strategic Global Advisors, LLC 48,154$7,442,0003.17%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders